Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide
Clinical trial NCT01729260 · COMPLETED
Trial details
- NCT number
- NCT01729260
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-04
- Primary completion
- 2016-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.